Atlas Trials

Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours

Clinical trial NCT06238336 · UNKNOWN

Trial details

NCT number
NCT06238336
Sponsor
Shanxi Bethune Hospital
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hematological Malignancy
Start date
2020-06-15
Primary completion
2025-11-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.